Definitive Healthcare Corp.

to definitive healthcare first quarter 2022 earnings conference call. At this time, all participants are in a listen mode, listen only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, David Samuels, General Counsel. Thank you, and over to you.

Good afternoon, and thank you for joining us today to review Definitive Healthcare's first quarter 2022 financial results. Joining the call today are Jason Krantz, Definitive Healthcare's founder and CEO, Robert Musselwhite, Definitive Healthcare's president, and Rick Booth, Definitive Healthcare's chief financial officer. During this call, we will make forward-looking statements, including, but not limited to, statements relating to our markets and future growth opportunities, the benefits of our healthcare commercial intelligence solutions, our competitive position, customer behaviors, our financial guidance, our planned investments, and the anticipated impact from the COVID-19 pandemic on our business and results of operations, as well as on our clients, the healthcare industry generally, and the macroeconomic environment. Any forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve a number of risks and uncertainties, including those discussed in the risk factor section of our filings with the SEC. Actual results may differ materially from forward-looking statements. The company undertakes no obligation to revise or update any forward-looking statements to reflect events that may arise after this conference call, except as required by law. For more information, please refer to the cautionary statements included in the earnings release that we just posted to the investor relations portion of our website. Additionally, we will discuss non-GAAP financial performance measures on this conference call. References on this call to profitability are on an adjusted EBITDA basis. Please refer to the tables in our earnings release on the investor relations portion of our website for a reconciliation of these measures to the most directly comparable GAAP financial measures. With that, I'd like to turn the call over to Jason.

Thanks, David. I would like to thank all of you for joining us this afternoon to discuss definitive health care's first quarter results. Before we go into more details on the quarter, I want to comment quickly on the news that went out today at the same time as our earnings press release. As you've likely read by now, I'm excited to announce that Robert Musselwhite, our current president, will become the Chief Executive Officer of Definitive Healthcare, effective August 1st, 2022. At that time, I will move into the role of Executive Chairman. This transition is exciting for the company and for me. For the company, Robert brings a wealth of healthcare industry expertise and a deep familiarity with running a public, healthcare-focused SaaS company. He is the perfect person to lead Definitive Healthcare through our next period of growth. On a personal level, transitioning to the executive chairman role will let me focus my attention on parts of the business I'm most passionate about, specifically product development and strategy, while still partnering with Robert on broader, long-term company strategy and mergers and acquisitions. Robert and I have developed a fantastic partnership over the last almost year working together, and I'm excited about continuing our partnership to take definitive healthcare to the next level. Now, let's get back to our Q1 results. We got off to a strong start in 2022, with important wins across each of our core markets and continued progress on our innovation roadmap. Our performance demonstrates the significant market opportunity for healthcare commercial intelligence, which we deliver through our comprehensive SaaS-based platform, our industry-leading data, and our proprietary data science-based analytics. We are at the very early stages of a $10 billion in growing market opportunity, and we believe that we are in a great position to generate strong growth and significant profitability for years to come. Let's start today by quickly reviewing our financial results for the quarter, which was highlighted by the company crossing $200 million in annualized revenue for the first time. Our total revenue was $50.1 million, which represents 36% year-over-year growth. And our adjusted EBITDA was 14 million, which translates into a 28% margin. These impressive results reinforce our ability to generate high growth and substantial profitability while at the same time investing organically and inorganically to support our long-term objectives. I'm now going to hand it over to Robert to talk more about some of the drivers of the success, as well as to highlight some key customer wins during the quarter.